Silver and Antibiotic, New Facts to an Old Story
- PMID: 30135366
- PMCID: PMC6163818
- DOI: 10.3390/antibiotics7030079
Silver and Antibiotic, New Facts to an Old Story
Abstract
The therapeutic arsenal against bacterial infections is rapidly shrinking, as drug resistance spreads and pharmaceutical industry are struggling to produce new antibiotics. In this review we cover the efficacy of silver as an antibacterial agent. In particular we recall experimental evidences pointing to the multiple targets of silver, including DNA, proteins and small molecules, and we review the arguments for and against the hypothesis that silver acts by enhancing oxidative stress. We also review the recent use of silver as an adjuvant for antibiotics. Specifically, we discuss the state of our current understanding on the potentiating action of silver ions on aminoglycoside antibiotics.
Keywords: ROS; adjuvant; antibiotics; combinatorial; metal; silver.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.
Figures
References
-
- Bartłomiejczyk T., Lankoff A., Kruszewski M., Szumiel I. Silver nanoparticles—Allies or adversaries? Ann. Agric. Environ. Med. 2013;20:48–54. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
